ImmunotherapyWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.AxillarySamplingTumorGradeDoseDenseTherapyTripleNegativeBreastCancerLymphoscintigraphyHormoneReplacementTherapyWomen ages40+ shouldhave a clinicalbreast examat least yearlyRADIntraductalPapillomaOvarianSuppressionBreastTomosynthesisMetastasisMethotrexateTyrosine-KinaseInhibitorECOGScoreFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.FISHCalcificationsFibroadenomaCheckpointInhibitorSERMLumpectomyInvasiveBreastCancerKi-67RateBiopsyAdenocarcinomaGenomicTestingChemotherapyMRIHER-2GermlineMutationCystBreastCancerAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCAMNeoplasmMastectomyBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55DefinitiveSurgeryCo-survivorAdvocacyApoptosisER+BI-RADSLapatinibCytostaticCytotoxicGuaranteedRenewableInsuranceBevacizumabPalbociclibPagetDiseaseNeoadjuvantTherapy1 in 8womenMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltKappaEpsilonBilateralProphylacticMastectomyExcisionalBiopsyBRCAGeneCDK4/6InhibitorsAngiogenesisIn-situCarcinomaAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerCMFChemotherapyPrecisionMedicineAntibodyTherapy5-FluorouracilOligometastasesAyurvedaMegestrolAcetateTamoxifenMultimodalityTherapyCyclophosphamideHerceptinGailModelEstradiolLumpCapecitabineEGFR(epidermalgrowth factorreceptor)PARPInhibitorsGeneMutationRelapseNodeNegativeCachexiaNodePositiveMultifocalTumorsDown-StagingLymphNodeStatusPhysicalactivity mayreduce therisk of breastcancersGeneticCounselingACChemotherapyPalpationAdjuvantTherapyBOCARaloxifeneEstrogenMorpheaAnastrozoleDimplingPI3KinaseInhibitorsAntiemeticStagingPhyllodesTumorMastodyniaFamilyHistoryHormoneReceptorStatusDoxorubicinEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearPathologicResponseAbsoluteRiskTriplePositiveBreastCancermTORInhibitorsAromataseInhibitorsLCISPaclitaxelProgestinRadiotherapyAlopeciaFlowCytometryBrachytherapyDocetaxelChemopreventionER-Self-examinationGeneticPredispositionImmunotherapyWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.AxillarySamplingTumorGradeDoseDenseTherapyTripleNegativeBreastCancerLymphoscintigraphyHormoneReplacementTherapyWomen ages40+ shouldhave a clinicalbreast examat least yearlyRADIntraductalPapillomaOvarianSuppressionBreastTomosynthesisMetastasisMethotrexateTyrosine-KinaseInhibitorECOGScoreFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.FISHCalcificationsFibroadenomaCheckpointInhibitorSERMLumpectomyInvasiveBreastCancerKi-67RateBiopsyAdenocarcinomaGenomicTestingChemotherapyMRIHER-2GermlineMutationCystBreastCancerAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCAMNeoplasmMastectomyBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55DefinitiveSurgeryCo-survivorAdvocacyApoptosisER+BI-RADSLapatinibCytostaticCytotoxicGuaranteedRenewableInsuranceBevacizumabPalbociclibPagetDiseaseNeoadjuvantTherapy1 in 8womenMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltKappaEpsilonBilateralProphylacticMastectomyExcisionalBiopsyBRCAGeneCDK4/6InhibitorsAngiogenesisIn-situCarcinomaAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerCMFChemotherapyPrecisionMedicineAntibodyTherapy5-FluorouracilOligometastasesAyurvedaMegestrolAcetateTamoxifenMultimodalityTherapyCyclophosphamideHerceptinGailModelEstradiolLumpCapecitabineEGFR(epidermalgrowth factorreceptor)PARPInhibitorsGeneMutationRelapseNodeNegativeCachexiaNodePositiveMultifocalTumorsDown-StagingLymphNodeStatusPhysicalactivity mayreduce therisk of breastcancersGeneticCounselingACChemotherapyPalpationAdjuvantTherapyBOCARaloxifeneEstrogenMorpheaAnastrozoleDimplingPI3KinaseInhibitorsAntiemeticStagingPhyllodesTumorMastodyniaFamilyHistoryHormoneReceptorStatusDoxorubicinEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearPathologicResponseAbsoluteRiskTriplePositiveBreastCancermTORInhibitorsAromataseInhibitorsLCISPaclitaxelProgestinRadiotherapyAlopeciaFlowCytometryBrachytherapyDocetaxelChemopreventionER-Self-examinationGeneticPredisposition

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
  1. Immunotherapy
  2. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  3. Axillary Sampling
  4. Tumor Grade
  5. Dose Dense Therapy
  6. Triple Negative Breast Cancer
  7. Lymphoscintigraphy
  8. Hormone Replacement Therapy
  9. Women ages 40+ should have a clinical breast exam at least yearly
  10. RAD
  11. Intraductal Papilloma
  12. Ovarian Suppression
  13. Breast Tomosynthesis
  14. Metastasis
  15. Methotrexate
  16. Tyrosine-Kinase Inhibitor
  17. ECOG Score
  18. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  19. FISH
  20. Calcifications
  21. Fibroadenoma
  22. Checkpoint Inhibitor
  23. SERM
  24. Lumpectomy
  25. Invasive Breast Cancer
  26. Ki-67 Rate
  27. Biopsy
  28. Adenocarcinoma
  29. Genomic Testing
  30. Chemotherapy
  31. MRI
  32. HER-2
  33. Germline Mutation
  34. Cyst
  35. Breast Cancer
  36. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  37. CAM
  38. Neoplasm
  39. Mastectomy
  40. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  41. Definitive Surgery
  42. Co-survivor
  43. Advocacy
  44. Apoptosis
  45. ER+
  46. BI-RADS
  47. Lapatinib
  48. Cytostatic
  49. Cytotoxic
  50. Guaranteed Renewable Insurance
  51. Bevacizumab
  52. Palbociclib
  53. Paget Disease
  54. Neoadjuvant Therapy
  55. 1 in 8 women
  56. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  57. Kappa Epsilon
  58. Bilateral Prophylactic Mastectomy
  59. Excisional Biopsy
  60. BRCA Gene
  61. CDK4/6 Inhibitors
  62. Angiogenesis
  63. In-situ Carcinoma
  64. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  65. CMF Chemotherapy
  66. Precision Medicine
  67. Antibody Therapy
  68. 5-Fluorouracil
  69. Oligometastases
  70. Ayurveda
  71. Megestrol Acetate
  72. Tamoxifen
  73. Multimodality Therapy
  74. Cyclophosphamide
  75. Herceptin
  76. Gail Model
  77. Estradiol
  78. Lump
  79. Capecitabine
  80. EGFR (epidermal growth factor receptor)
  81. PARP Inhibitors
  82. Gene Mutation
  83. Relapse
  84. Node Negative
  85. Cachexia
  86. Node Positive
  87. Multifocal Tumors
  88. Down-Staging
  89. Lymph Node Status
  90. Physical activity may reduce the risk of breast cancers
  91. Genetic Counseling
  92. AC Chemotherapy
  93. Palpation
  94. Adjuvant Therapy
  95. BOCA
  96. Raloxifene
  97. Estrogen
  98. Morphea
  99. Anastrozole
  100. Dimpling
  101. PI3 Kinase Inhibitors
  102. Antiemetic
  103. Staging
  104. Phyllodes Tumor
  105. Mastodynia
  106. Family History
  107. Hormone Receptor Status
  108. Doxorubicin
  109. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  110. Pathologic Response
  111. Absolute Risk
  112. Triple Positive Breast Cancer
  113. mTOR Inhibitors
  114. Aromatase Inhibitors
  115. LCIS
  116. Paclitaxel
  117. Progestin
  118. Radiotherapy
  119. Alopecia
  120. Flow Cytometry
  121. Brachytherapy
  122. Docetaxel
  123. Chemoprevention
  124. ER-
  125. Self-examination
  126. Genetic Predisposition